Albana, Rhesa C.

HRN: 17-54-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/03/2023
02/10/2023
IV
1.5g
Q6h
Dm Foot
Waiting Final Action 
02/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/03/2023
02/10/2023
IV
300 Mg
Q6h
Dm Foot
Waiting Final Action 
02/09/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/09/2023
02/13/2023
PO
500mg
OD
DM Foot
Waiting Final Action 
12/21/2024
CEFTAZIDIME 1GM (VIAL)
12/21/2024
12/27/2024
IV
500mg
Q24
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: